Capsaicin Alleviates Vascular Endothelial Dysfunction and Cardiomyopathy Via TRPV1/eNOS Pathway in Diabetic Rats
Overview
Endocrinology
Affiliations
Background: Endothelial dysfunction and cardiomyopathy are considered to be important vascular complications associated with diabetes. This study was designed to investigate whether capsaicin (CAP), a selective TRPV1 agonist, could prevent diabetes-induced endothelial dysfunction and cardiomyopathy.
Methods: Male Sprague Dawley rats aged 8 weeks were injected intraperitoneally with streptozotocin (STZ, 50 mg/kg) to establish the diabetes model. The diabetic rats were randomly divided into the untreated diabetes group (DM, 10/group) and diabetes plus CAP treatment group (DM+CAP, 10/group); meanwhile, the nondiabetic healthy rats were used as normal controls (10/group). DM+CAP group were treated with CAP by gavage for 8 weeks. The cultured mouse vascular endothelial cells were exposed to different concentrations of glucose in the presence or absence of CAP treatment. The TRPV1 inhibitor capsazepine (CPZ) and eNOS inhibitor L-NAME were used and experiment.
Results: CAP treatment significantly decreased the serum total cholesterol (TC) and total triglyceride (TG) and ameliorated the pathogenesis and fibrosis in the heart, while did not significantly improve plasma glucose level and the body weights of diabetic rats. In addition, CAP enhanced the expression of TRPV1 and eNOS in the heart and normalized the vascular permeability under diabetic state. Similarly, CAP treatment also increased nitric oxide and reduced reactive oxygen species. The same results were observed in cultured mouse vascular endothelial cells by CAP treatment. These beneficial effects of CAP were abolished by either CPZ or L-NAME.
Conclusions: CAP might protect against hyperglycemia-induced endothelial dysfunction and diabetic cardiomyopathy through TRPV1/eNOS pathway.
Lin J, Ou H, Luo B, Ling M, Lin F, Cen L Mol Med. 2024; 30(1):148.
PMID: 39266965 PMC: 11391744. DOI: 10.1186/s10020-024-00910-y.
A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM).
Yao P, Yang X, Qiao Y Rev Cardiovasc Med. 2024; 25(5):165.
PMID: 39076497 PMC: 11267204. DOI: 10.31083/j.rcm2505165.
Lee C, Wu S, Yang J, Chen W, Chen C, Chen H Arch Toxicol. 2024; 98(7):2247-2259.
PMID: 38635053 PMC: 11169047. DOI: 10.1007/s00204-024-03751-0.
Liu Y, Huo J, Ren K, Pan S, Liu H, Zheng Y Cell Death Discov. 2024; 10(1):148.
PMID: 38509100 PMC: 10954771. DOI: 10.1038/s41420-024-01918-3.
Role of TRP Channels in Metabolism-Related Diseases.
Wu F, Bu S, Wang H Int J Mol Sci. 2024; 25(2).
PMID: 38255767 PMC: 10815096. DOI: 10.3390/ijms25020692.